Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for SYK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 -185.00M
December 31, 2025 -305.00M
September 30, 2025 -321.00M
June 30, 2025 -104.00M
March 31, 2025 -4.136B
December 31, 2024 -303.00M
September 30, 2024 -2.172B
June 30, 2024 -117.00M
March 31, 2024 -408.00M
December 31, 2023 -152.00M
September 30, 2023 -145.00M
June 30, 2023 -533.00M
March 31, 2023 -132.00M
December 31, 2022 -162.00M
September 30, 2022 72.00M
June 30, 2022 -152.00M
March 31, 2022 -2.682B
December 31, 2021 -314.00M
September 30, 2021 -247.00M
June 30, 2021 -202.00M
March 31, 2021 -96.00M
December 31, 2020 -4.352B
September 30, 2020 -69.00M
June 30, 2020 -117.00M
March 31, 2020 -163.00M
Date Value
December 31, 2019 -719.00M
September 30, 2019 -186.00M
June 30, 2019 -247.00M
March 31, 2019 -303.00M
December 31, 2018 -1.628B
September 30, 2018 -156.00M
June 30, 2018 -233.00M
March 31, 2018 -854.00M
December 31, 2017 -559.00M
September 30, 2017 -815.00M
June 30, 2017 -192.00M
March 31, 2017 -146.00M
December 31, 2016 -177.00M
September 30, 2016 -102.00M
June 30, 2016 -3.969B
March 31, 2016 57.00M
December 31, 2015 -585.00M
September 30, 2015 315.00M
June 30, 2015 1.90B
March 31, 2015 326.00M
December 31, 2014 -88.00M
September 30, 2014 -424.00M
June 30, 2014 -1.015B
March 31, 2014 -351.00M
December 31, 2013 -291.00M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. -26.60M
Zimmer Biomet Holdings, Inc. -159.00M
Abbott Laboratories --
Boston Scientific Corp. -591.00M
Globus Medical, Inc. -182.67M